A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- BioMarin Pharmaceutical
- Study ID
- NCT06212947
- Status
- Recruiting
Conditions
- Hypochondroplasia
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 15 Years
- Healthy Volunteers
- Not accepted
Study Details
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Key Dates
- Start date
- Nov 27, 2023
- Status verified
- Apr 2025
- Primary completion
- Dec 31, 2043
- Completion
- Dec 31, 2043
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Children with HypochondroplasiaChildren with Hypochondroplasia
Primary Outcome Measure
Change in annualized growth velocity (AGV) [ Time Frame: Every 6 months through end of study, up to 15 years ]
Central Contacts
- Trial Specialist1-800-983-4587
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | - |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | - |
| UCSF Benioff Children's Hospital | Oakland | California | 94609 | - |
| Nemours Alfred I. Dupont Hospital for Children | Wilmington | Delaware | 19803 | - |
| Children's National Health System | Washington D.C. | District of Columbia | 20010 | - |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | - |
| The Johns Hopkins University School of Medicine | Baltimore | Maryland | 21218 | - |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | - |
| University of Minnesota Masonic Children's Hospital | Minneapolis | Minnesota | 55454 | - |
| University of Missouri | Columbia | Missouri | 65212 | - |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | - |
| Mount Sinai Kravis Children's Hospital | New York | New York | 10029 | - |
| Akron Children's Hospital | Akron | Ohio | 44307 | - |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | - |
| Cook Children's Endocrinology | Fort Worth | Texas | 76104 | - |
| Medical College of Wisconsin, Children's Hospital | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in Phoenix, AZ
By research site
Phoenix Children's Hospital· Phoenix, AZCedars-Sinai Medical Center· Los Angeles, CAUCSF Benioff Children's Hospital· Oakland, CANemours Alfred I. Dupont Hospital for Children· Wilmington, DEChildren's National Health System· Washington D.C., DCAnn & Robert H. Lurie Children's Hospital of Chicago· Chicago, IL
Related Studies
- Prospective Clinical Assessment Study in Children With HypochondroplasiaRecruiting · QED Therapeutics, a BridgeBio company · Oakland, California
- An Interventional Study of Infigratinib in Children With HypochondroplasiaPHASE2/PHASE3 · Enrolling By Invitation · QED Therapeutics, a BridgeBio company · Oakland, California
- Long-Term Extension Study of Vosoritide to Treat Children With HypochondroplasiaPHASE3 · Enrolling By Invitation · BioMarin Pharmaceutical · Wilmington, Delaware
- A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 MonthsPHASE2 · Recruiting · BioMarin Pharmaceutical · Phoenix, Arizona